Multidisciplinary patient-centered management of brain metastases and future directions
Joshua D. Palmer(The Ohio State University), David Roberge(Centre Hospitalier de l’Université de Montréal), Mark V. Mishra(University of Maryland, Baltimore), Michael D. Chan(Wake Forest University), Steven E. Schild(Mayo Clinic Hospital), Paul D. Brown(Mayo Clinic), Joseph Bovi(Froedtert Hospital), Giuseppe Minniti(Istituto Neurologico Mediterraneo), Maryam B. Lustberg(Yale Cancer Center), Chad G. Rusthoven(University of Colorado Cancer Center), Daniel M. Trifiletti(Mayo Clinic in Florida), Vinai Gondi(Thomas Jefferson University Hospital), Nicole Williams(The Ohio State University), Ganesh Rao(Baylor College of Medicine)
Cited by 50
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k